Ovestin (Estriol)

Estriol, the active ingredient in Ovestin, is an estrogen hormone presented as a 0.5 mg/1 tablet for oral use. It treats menopausal symptoms and is used in hormone replacement therapy for post‑menopausal women. GNH USA supplies Ovestin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Ovestin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Ovestin is an estrogen medication that acts on the hormonal pathways involved in menopause and related conditions.

- Menopausal vasomotor symptoms: Reduces the frequency and severity of hot flashes. - Vaginal atrophy: Improves vaginal lubrication and tissue health. - Osteoporosis prevention: Contributes to bone density maintenance in post‑menopausal women.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Nausea: Mild to moderate stomach upset. - Breast tenderness: Sensitivity or swelling of breast tissue. - Headache: Transient head pain. - Fluid retention: Mild swelling of ankles or hands. - Mood changes: Irritability or mild depressive symptoms. - Vaginal bleeding: Spotting or breakthrough bleeding.

Serious or Rare Side Effects: - Thromboembolic events: Deep vein thrombosis or pulmonary embolism. - Stroke: Cerebrovascular accident, especially in high‑risk patients. - Liver dysfunction: Elevated liver enzymes or cholestasis. - Endometrial hyperplasia: Abnormal thickening of the uterine lining. - Breast cancer: Potential increased risk with long‑term use. - Allergic reaction: Rash, itching, or anaphylaxis.

When prescribing Ovestin, clinicians should consider several safety aspects.

- Contraindication: Do not use in women with known estrogen‑dependent tumors. - Cardiovascular risk: Assess history of thromboembolism or stroke before initiating therapy. - Liver function: Monitor hepatic enzymes in patients with liver disease. - Bone health: Evaluate baseline bone mineral density when used for osteoporosis prevention. - Breast screening: Encourage regular mammography during treatment. - Store at ambient temperature: Keep below 25°C in the original packaging, protected from moisture.

Estradiol may interact with a range of concomitant medications.

Major Interactions (Avoid): - Warfarin: Increases anticoagulant effect, raising bleeding risk. - CYP3A4 inhibitors: Such as ketoconazole, may raise estradiol plasma levels. - Aromatase inhibitors: Counteract estrogenic activity, reducing therapeutic effect.

Moderate Interactions (Monitor Closely): - Anticonvulsants: Phenytoin, carbamazepine may lower estradiol concentrations. - Selective serotonin reuptake inhibitors (SSRIs): May alter hormone metabolism. - Thyroid hormones: Levothyroxine absorption can be affected.